HealthDay’s Mabel Jong is joined by Dr. David W. Bates, an internationally renowned expert in patient safety and health care technology, to discuss the current landscape of health apps and how these tools can be used to improve the management and treatment of chronic conditions.
Yoga, meditation and other mindfulness practices may help people with type 2 diabetes lower their blood sugar — nearly to the degree that standard medications like metformin do, a new analysis suggests.
That does not mean people should swap their medication for
Overall use of insulin pumps among U.S. youngsters with type 1 diabetes has climbed in recent decades, but those who are poor or from minority groups are less likely to have the devices, a new study finds.
Insulin pumps, which do away with the need for numerous painful injections, have been shown to ...
High-tech devices and communication helped ease the impact of COVID-19 lockdowns on children with type 1 diabetes, researchers said in a new study.
Pandemic shutdowns caused significant disruptions in health care, and previous studies have shown that diabetes patients had worse blood sugar (glucose) control and more difficulty accessing care during the early days of the pandemic.
Newly diagnosed diabetes in many COVID-19 patients may be a temporary type triggered by COVID, according to a new study.
Blood sugar levels returned to normal in about half of the newly diagnosed diabetes patients after they left the hospital, and only 8% required insulin after one year, according to the report published online recently in the
Having a child with type 1 diabetes can be a challenging health condition for parents to manage, but new research suggests an "artificial pancreas" system may beat standard treatment in controlling the blood sugar disease in young children.
Forms of the technology -- which automatically monitors and regulates blood sugar -- are already available for adults and kids with
Scientists have known for 100 years that insulin is the body's main mechanism for controlling blood sugar levels, but researchers have now discovered a second hormone does the same job a bit differently -- and they say it could be a new target for treating diabetes.
The hormone, called FGF1, is produced in the body's fat tissue. Like
Medtronic has expanded a recall of its MiniMed 600 series insulin pumps to include more than 463,000 of the devices.
The pumps may deliver incorrect dosing of insulin and the recall has been identified by the U.S. Food and Drug Administration as a Class I recall -- the most serious type -- because use of the recalled devices may cause serious harm or death.
Statins are proven to lower cholesterol, but they may also come with a downside for patients with diabetes: A new study finds they may make the blood sugar disease worse.
Researchers found that among those taking statins, 56% saw their diabetes progress, compared with 48% of those not taking statins. And the higher the dose of the statin, the faster the progression of the diabetes.
Older adults who take certain diabetes drugs may see a slower decline in their memory and thinking skills, a new study suggests.
Researchers in South Korea found that among older people who'd been having memory issues, those using diabetes drugs called DDP-4 inhibitors typically showed a slower progression in those symptoms over the next few years. That was compared with both diabetes-fre...
As many Americans know, today's health insurance plans often come with high deductibles. Those out-of-pocket costs could cause harm: New research shows that 20% of people who have diabetes and high-deductible health plans regularly skip their medications.
Not keeping up with your diabetes medications comes with the potential risk of an emergency room visit or a hospitalization.
U.S. pharmacists will now be able to automatically substitute a cheaper biosimilar for a more expensive brand-name insulin, the U.S Food and Drug Administration announced Wednesday.
The agency's approval of an "interchangeable" biosimilar could save diabetics and health plans millions each year, the Associated Press reported. Until now, doctors have had to specifically prescribe ...
People with type 2 diabetes face heightened risks for heart attack and stroke, as well as progressive kidney disease. But a new once-a-week injected drug called efpeglenatide could greatly reduce their odds for those outcomes, new research shows.
The clinical trial was conducted in over 28 nations and involved more than 4,000 patients with type 2 diabetes.
Over two years, patients ...
Robert Preidt and Ernie Mundell HealthDay Reporters
Hospitalized patients with diabetes who hadn't been taking their medication had more severe cases of COVID-19, a new study shows.
"Our results highlight the importance of assessing, monitoring and controlling blood glucose [sugar] in hospitalized COVID-19 patients from the start," said study author Sudip Bajpeyi, associate professor of kinesiology at the University of Texas at El Paso. H...
After years of improvement, Americans with diabetes may be losing some ground in controlling the condition, a new government-funded study shows.
Researchers found that between 1999 and the early 2010s, U.S. adults with diabetes made substantial gains: A growing percentage had their blood sugar, blood pressure and cholesterol down to recommended levels.
Severe high and low blood sugar events in older adults with type 1 diabetes may significantly increase their risk of dementia, according to a new study.
"For people with diabetes, both severely high and low blood sugar levels are emergencies and both extremes can largely be avoided," said study author Rachel Whitmer, associate director of the Alzheimer's Disease Research Center at the Uni...
An aggressive weight-loss program not only achieves remission of type 2 diabetes, but may also end the need for blood pressure medications, new research shows.
"Our study shows that, in addition to possible remission from type 2 diabetes, there are other very important health benefits, as weight loss is a very effective treatment for hypertension [high blood pressure] and its associated s...
Even after suffering a stroke, many Hispanic Americans still have uncontrolled diabetes, high blood pressure or other conditions that raise their risk of a repeat one, a new study finds.
The study involved 404 Hispanic adults with a history of stroke or "mini-stroke," which is a brief reduction in blood flow to the brain that can foreshadow a full-blown stroke. The researchers found that ...
"Prediabetes" -- where blood sugar levels are high but not yet tipped over into full-blown diabetes -- may pose a threat to brain health, new British research suggests.
"As an observational study, it cannot prove higher blood sugar levels cause worsening brain health. However, we believe there is a potential connection that needs to be investigated further," said study lead author Victori...
Ernie Mundell and Robert Preidt HealthDay Reporters
The earlier in life type 2 diabetes arises, the deadlier it is, a new analysis finds.
The study, which pooled the results of 26 previous ones, revealed a clear pattern: The younger people were when they developed type 2 diabetes, the greater their risk of complications like heart disease and stroke.
For each year type 2 diabetes was delayed, the risk of blood vessel diseases fell by...
Weight-loss surgery conquers type 2 diabetes in more than 50% of patients who have the procedure, new research shows.
So-called bariatric surgery helps severely obese people shed weight and improve their health. Two types of weight-loss surgery are lap band surgery (in which a band around the top of the stomach creates a pouch that can only hold a small amount of food) and gastric bypass....
A small study suggests that a new procedure that treats part of the intestine just beyond the stomach may allow people with type 2 diabetes to safely stop taking insulin.
The procedure -- which resurfaces the duodenum -- was combined with a popular kind of diabetes medication called GLP-1 receptor agonists (such as Victoza, Trulicity, Ozempic) and counseling on lifestyle factors, such a...
When the COVID-19 pandemic began, many doctors started providing care via telemedicine. Now, a new survey of people with type 1 diabetes suggests many like remote care and hope it continues in the future.
Among the survey respondents who had a telemedicine visit during the pandemic, 86% found the remote appointments useful, and 75% said they planned on having remote appointme...